Active Surveillance Is the Preferred Approach to Clinical Stage I Testicular Cancer

Risk of second cancers among a cohort of 2,703 long-term survivors of testicular seminoma treated with radiotherapy.

(2017) A. Horwich et al.   JOURNAL OF CLINICAL ONCOLOGY

Management of testicular neoplasms in France and compliance with national guidelines.

(2017) S. Culine et al.   JOURNAL OF CLINICAL ONCOLOGY

Relapses in metastatic germ-cell tumors and relationship to international guidelines compliance: A study from the Institut Gustave Roussy.

(2017) Constance Thibault et al.   JOURNAL OF CLINICAL ONCOLOGY

Canadian consensus guidelines for the management of testicular germ cell cancer

(2016) Lori Wood et al.   CUAJ-Canadian Urological Association Journal

Barriers to the Implementation of Surveillance for Stage I Testicular Seminoma

(2012) Nils D. Arvold et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group

(2011) Torgrim Tandstad et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214)

(2011) R. Timothy D. Oliver et al.   JOURNAL OF CLINICAL ONCOLOGY

Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies

(2010) C. Kollmannsberger et al.   ANNALS OF ONCOLOGY

Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy

(2009) C. Kollmannsberger et al.   ANNALS OF ONCOLOGY

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

(2009) Torgrim Tandstad et al.   JOURNAL OF CLINICAL ONCOLOGY

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

(2008) Susanne Krege et al.   EUROPEAN UROLOGY

Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group

(2008) Peter Albers et al.   JOURNAL OF CLINICAL ONCOLOGY